Upcoming Events
Log In
Pricing
Free Trial

Wk 5, Case 4 - Review

HIDE
PrevNext

0:06

Prostate cancer with more, um, noal involvement.

0:11

This one here, just everything

0:18

just to see when you look at the here, um,

0:29

from the top, see there are

0:34

some lower cervical sub clavicular, no cervical lymph nodes.

0:38

And then when we go down there are

0:40

medicinal lymph nodes as well.

0:43

Para lymph nodes or aortic lymph nodes tracking down.

0:50

Then many large intensely PSMA avid retro

0:56

lymph nodes

1:04

and some therapy lymph lymph nodes, right?

1:07

So a lot of nodal disease,

1:14

right?

1:15

Interestingly so a lot of nodal disease.

1:17

This patient most probably had, um, mediation.

1:20

Tell little bit about the history of this patient.

1:26

We had castration, uh, since the, some

1:30

of the post had radi prostatectomy then uh,

1:33

salvage radiation therapy, um,

1:37

and coming with chemical recurrence.

1:39

This is why you see that the pelvis is more

1:43

or less clean, right?

1:50

And if you wanna know, if you wanna make sure

1:52

that there is radiation the same as we look at,

1:58

I like to look at the,

2:06

okay, something,

2:12

the reason I looked at this is

2:13

because look, here's like you have all these noal disease

2:16

and then a propped stopping here.

2:19

So this give me the, the feeling

2:22

that there isation done before.

2:25

This is why the nodal base is down for,

2:27

there is a course dissection here and prostatectomy here

2:31

and the prostatectomy bed.

2:32

This is what we see here is um, bladder or neck funneling.

2:37

Yeah, this is, so this is not recurrence,

2:38

this is just funneling after the prostatectomy.

2:42

It happens. Um, but this is not recurrent disease

2:46

and the prostatectomy bed or anything, everything is clean

2:50

and there is no dissection with nothing in the pelvis.

2:53

But this is really, if you look here in the pit only image,

2:56

the book is really, this is um,

3:00

Subjectivity in the ureter and then it's not.

3:03

This is the first node they see here.

3:05

See this is utic activity and there's the node here.

3:08

You start here. So, and here.

3:12

So not till the aorta, you start seeing something right

3:16

high up in theum.

3:18

So a lot of nodal disease in the abdomen,

3:21

the liver is clean as well.

3:24

Look how is that The liver is really clean

3:27

and the nodal disease tracking the me and left s region.

3:33

What is also important look at um,

3:41

zoom out so you can see

3:44

is we look at the bones, right?

3:46

Because prostate cancer loves the bone, right?

3:50

You have to make sure that there's no bone meds.

3:52

PMA wise, the pet only is negative and,

3:55

and PMA sensitive for bone mets.

3:57

It's not like xmen. We used to do do a lot of xmen

4:00

before the p cm A got a day approval

4:02

and Xmen had the limitation of um,

4:06

not being sensitive for bone meds.

4:09

So in Xmen, when we see

4:11

xmen act xmen AVID bone meds, it is bone meds.

4:14

But when we don't see any al validity in the bone,

4:18

it does not mean that there's no, uh, it had the full, uh,

4:22

negative uh, rate was high for ate.

4:25

So it doesn't exclude. There is, there's um,

4:28

bone metastasis that we're not seeing.

4:30

It's not the case with P-S-M-A-S-M-A sensitive

4:33

for bone, bone metastasis.

4:34

So, um, there's no piece morbidity.

4:38

But also we look at the bone itself here in the,

4:41

in the bone window there is really

4:44

nothing suspicious in the bone window.

4:46

So it looks like this patient is, doesn't have bone meta,

4:50

metastatic bone disease, osteo lesions.

4:53

We're seeing just strength of changes right now.

4:58

The next thing is the lung.

5:05

There were some nodules in the lung

5:08

which looked degenerative like, um,

5:13

sorry, disease.

5:16

There was some ERs disease. That's it.

5:19

There's nothing that looked metastatic diseases, the lung.

5:22

So basically this patient had

5:25

predominantly nodal disease.

5:29

That's it. This is all the patient had.

5:32

Um, BSA added nodal disease.

5:34

And the last thing I wanna talk about is this.

5:36

Here, this is contamination.

5:38

And when you see something like that, it's obviously

5:40

outside the patient, right?

5:42

And my trick here is I put the CT in the long window

5:45

and then you can see the hy pad

5:49

that the activities there to confirmation.

5:54

And that's it. This patient.

Report

Please note: Items with dashed lines (--) are information withheld as it is not relevant for you to arrive at the correct findings and impression for the report and/or it was withheld for privacy information. The items were left in to show you the typical information documented in a PET report.

Clinical Indication:
--year-old male with history of metastatic castration-sensitive adenocarcinoma of prostate, status post radical prostatectomy followed by postoperative/salvage radiotherapy completed, presenting with biochemical recurrence for subsequent treatment planning.

PSA levels:
Most recent 59.18 ng/mL, compared to 14.64 ng/mL/

Technique:
Radiopharmaceutical: ----- mCi of F-18 piflufolastat (PSMA, Pylarify) administered IV at -----at -----.
Incubation interval: ---- minutes.
Oral contrast: -----.
Positioning: Arms by sides.
PET/CT scanner: ----------.
PET/CT acquisition: Vertex-to-mid-thighs.
Standardized uptake value (SUV): Corrected for body weight only.
CT: non-breath-hold, without intravenous contrast.
TOTAL DLP (Dose Length Product): -------- mGy cm.

Comparison/Correlation:
No comparison. No correlative imaging.

Findings:
Technical quality: Adequate.
Measurements: Unless otherwise specified, all SUVs refer to maximum value in the target.
CT linear measurements performed on axial images.


Head and Neck:
Two intensely PSMA avid left supraclavicular lymph nodes, the larger one measures 19 x 14 mm maximum SUV 13.45.
No other suspicious PSMA avid lesions.


Chest:
- Multiple PSMA-avid posterior lower mediastinal lymph nodes within the prevertebral and para-esophageal regions. Index nodes are:

- 16 x 14 mm left para-esophageal lymph node maximum SUV 52.1
7 x 6 mm left paratracheal lymph node maximum 15.4

Multiple scattered small sub-centimeter pulmonary and pleural based nodules, many of which are partially calcified, showing no significant PSMA uptake above background level, favors granulomatous inflammatory etiology. Attention on follow up exams recommended.
No pleural effusion, pericardial effusion or pneumothorax.
Aortic and coronary calcifications.


Abdomen and Pelvis:
Multiple intensely PSMA-avid enlarged metastatic retroperitoneal lymph nodes. Index nodes are:

- 26 x 28 mm portacaval lymph node maximum SUV 46.8
- 30 x 27 mm pancreaticoduodenal maximum SUV of 43.7
- 32 x 23 mm left para-aortic nodal conglomerate with maximum SUV 46.1

Surgical changes from radical prostatectomy with no evidence of PSMA-avid recurrent disease.
Mild to moderate right hydronephrosis with dilated upper two third of the right ureter down to the level of aortic bifurcation appears to be caused by crossing right common iliac artery.
Unremarkable liver, gallbladder, spleen, pancreas, left kidney and adrenals.
Calcified atherosclerotic changes.
Urinary bladder neck funneling.
No ascites.


Skeleton and Soft Tissues:
No suspicious PSMA avid osseous or soft tissue lesions.
No aggressive lytic or sclerotic lesions.
Multilevel degenerative changes.
Contamination within a hygiene pad.

Impression:
1. Intensely PSMA-avid metastatic left supraclavicular, mediastinal and retroperitoneal adenopathy.
2. Surgical changes from radical prostatectomy with no evidence of PSMA-avid recurrent disease.
3. Multiple scattered small sub-centimeter pulmonary and pleural based nodules, many of which are partially calcified, showing no significant PSMA uptake above background level, favors benign/granulomatous inflammatory etiology. Attention on follow up exams recommended.
4. Mild to moderate right hydronephrosis with dilated upper two third of the right ureter down to the level of aortic bifurcation, with obstruction appears to be caused by crossing right common iliac artery.

Case Discussion

Faculty

Riham El Khouli, MD

Associate Professor of Radiology, Chief, Division of Nuclear Medicine/Molecular Imaging & Radiotheranostics

University of Kentucky

Michael F. Shriver, MD

Director of Nuclear Medicine

Proscan-NCH Imaging

Tags

Prostate/seminal vesicles

PET/CT PSMA

PET

Nuclear Medicine

CT